Foxp3+ T-regulatory cells in Sjogren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors
about
Sex differences in Sjögren's syndrome: a comprehensive review of immune mechanismsT Regulatory and T Helper 17 Cells in Primary Sjögren's Syndrome: Facts and PerspectivesReviewing primary Sjögren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatmentPeripheral regulatory cells immunophenotyping in primary Sjögren's syndrome: a cross-sectional study.Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection.The histopathology of labial salivary glands in primary Sjögren's syndrome: focusing on follicular helper T cells in the inflammatory infiltrates.Selective localization of T helper subsets in labial salivary glands from primary Sjögren's syndrome patients.Th17/Treg ratio in human graft-versus-host disease.Chitinases in the salivary glands and circulation of patients with Sjögren's syndrome: macrophage harbingers of disease severity.Distribution of Peripheral Lymphocyte Populations in Primary Sjögren's Syndrome Patients.Current Aspects of Pathogenesis in Sjögren's Syndrome.B-cell and T-cell quantification in minor salivary glands in primary Sjögren's syndrome: development and validation of a pixel-based digital procedureSerologic features of primary Sjögren's syndrome: clinical and prognostic correlationSjögren's syndrome-like ocular surface disease in thrombospondin-1 deficient mice.Systemic and local interleukin-17 and linked cytokines associated with Sjögren's syndrome immunopathogenesisThe contribution of epigenetics in Sjögren's Syndrome.Delivery of Bone Marrow-Derived Mesenchymal Stem Cells Improves Tear Production in a Mouse Model of Sjögren's Syndrome.Age-related spontaneous lacrimal keratoconjunctivitis is accompanied by dysfunctional T regulatory cells.Disturbance of cytokine networks in Sjögren's syndrome.Immunopathologic differences of Sjögren's syndrome versus sicca syndrome in HCV and HIV infection.The T cell in Sjogren's syndrome: force majeure, not spectateur.T Helper 17 Cells in Primary Sjögren's Syndrome.Identification of Novel CD4+ T Cell Subsets in the Target Tissue of Sjögren's Syndrome and Their Differential Regulation by the Lymphotoxin/LIGHT Signaling Axis.Primary Sjögren's syndrome: clinical phenotypes, outcome and the development of biomarkers.Characterization of a new regulatory CD4+ T cell subset in primary Sjögren's syndrome.Estimating cell count and distribution in labeled histological samples using incremental cell search.Evaluation of histologic, serologic, and clinical changes in response to abatacept treatment of primary Sjögren’s syndrome: a pilot study.Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation.Expression of type III interferons (IFNλs) and their receptor in Sjögren's syndrome.Effects of Aging in Dry Eye.Elevated level of circulating CD4+Helios+FoxP3+ cells in primary Sjogren's syndrome patients.MicroRNA in Sjögren's Syndrome: Their Potential Roles in Pathogenesis and Diagnosis.Mesenchymal Stem Cells in Primary Sjögren's Syndrome: Prospective and Challenges
P2860
Q26780324-DE0DEFD1-4DA0-4151-A928-91B6D3332624Q26859226-CDCD4EA0-4D7B-4101-B918-E3A7B48BFA61Q30234992-3CB40A34-CD0D-44FF-9C56-316496F0D541Q33766714-85AACBDE-DFAE-4B01-B84F-1F5A8F8A6D2AQ34031257-5267EF18-C7FB-44F1-8493-8C2C1F55C64CQ34080249-55F58F5C-F8F9-4880-B3A1-4CE3D40CB365Q34330859-558B9302-E083-440B-B1AE-0747FBEABAD0Q34403757-81CDA17E-7885-4690-80F9-87E41BF2B128Q35242525-56067274-F82B-482F-BD70-BC0A4E795597Q35673732-3BA9B0A4-CE7F-425B-9710-106988A367A9Q36059424-7F3813CA-1A22-47AD-ABE3-5743A7575429Q36481706-5DE570CE-DA2B-4EB2-B76C-C202BA0EB5B2Q36700816-698082D6-4139-42E5-8EAB-9BDDB8587C0CQ37316518-7FE86F54-F640-4ED9-AFAE-E8B1668FE043Q37316528-9D01D70C-A4B4-4FBE-BC16-4C4D9BE28D62Q37695272-169E2A24-9781-44FD-9477-2CFAA6DF46BAQ37703599-83227051-EEC1-4CC4-8A5D-6C1B87016CCEQ37737497-A10B01EE-A22E-4A06-A126-9D7E5E9864B3Q37899957-322C08FF-C059-456B-B070-9A137BB146C9Q37925863-A802EA3B-6B3B-4C54-9FC6-C63896ED1ADDQ38019664-36EF6AB3-8C2E-4E5A-A4A6-DED0CF78DDF3Q38693137-E0B93D79-2A2C-4F37-8481-4A288E66B285Q38798414-906B2C72-4FC9-4AA3-814F-B6B834ADDFE9Q38905170-0E76D181-8DBE-4B23-BEB5-49CF1F83DA73Q39418862-260BD790-79A7-47C3-A6B8-D0A43F2FF0F9Q42776758-A466CF3C-1D4A-4621-8CF1-17C9A1C675C7Q44697565-54A19797-4CB1-44DE-A0FD-342CBAE3B406Q47442388-E9FF9B2F-083C-48BC-8495-8C0EBCC7C840Q51524101-B375318D-EF63-4A6B-8E07-D2A802A746C2Q51836466-F788CF84-243C-4564-848E-661DA66CDA7CQ54400978-E0729BB2-1531-4F67-BD2E-E9A7021795C2Q55492467-BEF94301-F94B-4EEC-AFD6-669C0823421AQ57300327-D1CF123F-C6F3-46CB-91F9-DB4E6305980F
P2860
Foxp3+ T-regulatory cells in Sjogren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Foxp3+ T-regulatory cells in S ...... ain adverse prognostic factors
@en
type
label
Foxp3+ T-regulatory cells in S ...... ain adverse prognostic factors
@en
prefLabel
Foxp3+ T-regulatory cells in S ...... ain adverse prognostic factors
@en
P2093
P2860
P1476
Foxp3+ T-regulatory cells in S ...... ain adverse prognostic factors
@en
P2093
Efstathia K Kapsogeorgou
Haralampos M Moutsopoulos
Maria I Christodoulou
Niki M Moutsopoulos
P2860
P304
P356
10.2353/AJPATH.2008.080246
P407
P577
2008-09-25T00:00:00Z